Novan Provides SB206 Program and Business Update
February 06, 2020 08:30 ET
|
Novan, Inc.
FDA grants Type C meeting for SB206 to be held on April 1, 2020Last subject completes last visit, Week 24 safety evaluationAdditional 12-week efficacy and safety data provided MORRISVILLE, N.C., Feb....
Novan Reports Top-Line Efficacy Results from Phase 3 Trials of SB206 for Molluscum Contagiosum
January 02, 2020 16:15 ET
|
Novan, Inc.
Company to hold conference call Friday, January 3, 2020 at 8:30 am Eastern TimeFocus of call: top-line efficacy data and sensitivity analyses MORRISVILLE, N.C., Jan. 02, 2020 (GLOBE NEWSWIRE) --...
Novan Announces Planned Chief Executive Officer Transition
December 18, 2019 08:00 ET
|
Novan, Inc.
Paula Brown Stafford appointed as CEO effective February 2, 2020G. Kelly Martin’s term as CEO will end on February 1, 2020, per his employment contractMr. Martin will step down from the Novan Board of...
Novan Further Expands its Proprietary Nitric Oxide Platform
October 18, 2019 08:30 ET
|
Novan, Inc.
A new product candidate, SB207, to target anti-viral opportunitiesPre-IND meeting anticipated in December 2019Development of SB207 to be focused on indications with unmet patient need, such as...
Novan’s Phase 2 SB206 Molluscum Study Published in Journal of the American Academy of Dermatology
October 08, 2019 08:30 ET
|
Novan, Inc.
MORRISVILLE, N.C., Oct. 08, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today announced that the Company’s Phase 2 molluscum study, designed to evaluate topical...
Novan Awarded Approximately $1.1 Million Grant by Department of Defense
September 20, 2019 08:30 ET
|
Novan, Inc.
Funds to progress women’s health product candidate, WH504Additive to recently announced NIH grant for WH602Women’s health initiative to focus on potential HPV related onco-virus therapeutics ...
Novan Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 11, 2019 16:05 ET
|
Novan, Inc.
MORRISVILLE, N.C., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today announced that the Compensation Committee of Novan’s Board of Directors granted stock...
Novan and Aspire Capital Enter into a Common Stock Purchase Agreement for up to $25 Million
September 05, 2019 06:30 ET
|
Novan, Inc.
MORRISVILLE, N.C., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today announced that the Company has entered into a Common Stock Purchase Agreement (the...
Novan Hires Michelle Patterson as Vice President of Project Management
September 03, 2019 16:05 ET
|
Novan, Inc.
Underscores Company’s preparation for potential NDA submission for SB206 in molluscumRole to lead cross-functional coordination of key activities and timelines for the programSB206 top line results...
Novan to Participate in H.C. Wainwright 21st Annual Global Investment Conference
September 03, 2019 09:00 ET
|
Novan, Inc.
MORRISVILLE, N.C., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that it will participate in the H.C. Wainwright 21st Annual Global...